Guardian Pharmacy Services, Inc.
GRDNNYSECIK 1802255Consumer staplesFiscal year ends Dec 31
Latest reported revenue, Q2 FY2026$351.8mRevenue, Q2 FY2026, three months to 2026-06-30$351.8m. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 6, 2026.Latest quarter: Q2 FY2026
Three months to Jun 30, 2026, against the same quarter a year earlier.
- Revenue$351.8mRevenue, Q2 FY2026, three months to 2026-06-30$351.8m. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure+2.2% on a year earlier - Gross margin22.8%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $80.0m. XBRL concept
us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $351.8m. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure+3.0 pts on a year earlier - Operating margin5.9%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $20.6m. XBRL concept
us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $351.8m. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure+2.2 pts on a year earlier - Net margin6.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $21.9m. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $351.8m. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure+3.6 pts on a year earlier - Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
- Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare
Last eight quarters
Full statements| Line item | Unit | Q3 FY20242024-09-30 | period not labelled2024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | 314Revenue, Q3 FY2024, three months to 2024-09-30$314.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 339Revenue, period not labelled, three months to 2024-12-31$338.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 329Revenue, Q1 FY2025, three months to 2025-03-31$329.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 344Revenue, Q2 FY2025, three months to 2025-06-30$344.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | 377Revenue, Q3 FY2025, three months to 2025-09-30$377.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 398Revenue, Q4 FY2025, three months to 2025-12-31$397.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 337Revenue, Q1 FY2026, three months to 2026-03-31$336.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 352Revenue, Q2 FY2026, three months to 2026-06-30$351.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | |
| Gross margin | % | 19.4%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $60.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Revenue: $314.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 19.8%Gross margin, period not labelled, three months to 2024-12-31. gross profit / revenueGross profit: $67.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Revenue: $338.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 19.5%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $64.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Revenue: $329.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 19.8%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $68.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $344.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | 19.8%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $74.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Revenue: $377.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 21.5%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $85.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Revenue: $397.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 22.7%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $76.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Revenue: $336.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 22.8%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $80.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $351.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | |
| Operating margin | % | (33.3%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$104.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Revenue: $314.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 4.9%Operating margin, period not labelled, three months to 2024-12-31. operating income / revenueOperating income: $16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Revenue: $338.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 3.9%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Revenue: $329.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 3.7%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $344.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | 4.3%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $16.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Revenue: $377.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 7.7%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $30.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Revenue: $397.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 5.3%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Revenue: $336.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 5.9%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $20.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $351.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | |
| Net margin | % | (38.8%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$122.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Revenue: $314.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 3.5%Net margin, period not labelled, three months to 2024-12-31. net income / revenueNet income: $11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Revenue: $338.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 2.9%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $329.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 2.6%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $344.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | 2.6%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Revenue: $377.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001193125-25-274298.Report this figure | 5.3%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Revenue: $397.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | 3.9%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $336.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001193125-26-209021.Report this figure | 6.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Revenue: $351.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338074.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | |
| Free cash flow | $m | (4.4)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274298. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.2m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-10, accession 0001193125-25-274298. Derived: 9-month figure less the 6-month figure.Report this figure | 20.1Free cash flow, period not labelled, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | 24.2Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $28.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001193125-25-274298. Derived: 9-month figure less the 6-month figure.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-10, accession 0001193125-25-274298. Derived: 9-month figure less the 6-month figure.Report this figure | 34.1Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $34.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Capital expenditure: $495.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-11, accession 0001193125-26-102172. Derived: 12-month figure less the 9-month figure.Report this figure | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY2024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|
| Revenue | $m | 1,228Revenue, period not labelled, twelve months to 2024-12-31$1.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | 1,449Revenue, FY2025, twelve months to 2025-12-31$1.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | |
| Gross margin | % | 19.9%Gross margin, period not labelled, twelve months to 2024-12-31. gross profit / revenueGross profit: $244.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-11, accession 0001193125-26-102172.Revenue: $1.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | 20.2%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $292.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-11, accession 0001193125-26-102172.Revenue: $1.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | |
| Operating margin | % | (5.1%)Operating margin, period not labelled, twelve months to 2024-12-31. operating income / revenueOperating income: −$62.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172.Revenue: $1.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | 5.0%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $72.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172.Revenue: $1.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | |
| Net margin | % | (9.0%)Net margin, period not labelled, twelve months to 2024-12-31. net income / revenueNet income: −$110.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172.Revenue: $1.23bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | 3.4%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $49.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-11, accession 0001193125-26-102172.Revenue: $1.45bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | |
| Free cash flow | $m | 43.3Free cash flow, period not labelled, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $58.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-11, accession 0001193125-26-102172.Capital expenditure: $14.7m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure | 86.8Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $100.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-11, accession 0001193125-26-102172.Capital expenditure: $13.4m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-11, accession 0001193125-26-102172.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| FMR LLC | 2026-06-30 | $135.7m | 3,241,612 | Added+882,255 | |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-06-30 | $72.4m | 1,729,032 | Reduced−36,087 | |
| BlackRock, Inc. | 2026-06-30 | $66.0m | 1,575,989 | Reduced−180,385 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-06-30 | $57.8m | 1,379,750 | Added+154,207 | |
| Woodline Partners LP | 2026-06-30 | $54.7m | 1,306,340 | Added+22 | |
| Valiant Capital Management, L.P. | 2026-06-30 | $49.7m | 1,186,658 | Unchanged | |
| Boston Partners | 2026-06-30 | $40.8m | 983,868 | Reduced−33,815 | |
| FRANKLIN RESOURCES INC | 2026-06-30 | $40.5m | 966,206 | Added+13,254 | |
| TimesSquare Capital Management, LLC | 2026-06-30 | $39.8m | 951,637 | Reduced−125,837 | |
| LOOMIS SAYLES & CO L P | 2026-06-30 | $36.4m | 869,836 | Reduced−61,853 |
Recent filings
All 216 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2817:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-405492 |
| 2026-09-1016:05 ET | 8-K | 8.01 Other events | 0001193125-26-387858 |
| 2026-08-0616:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338074 |
| 2026-08-0616:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338032 |
| 2026-06-2216:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-277596 |
| 2026-05-2816:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-245235 |
| 2026-05-0716:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-211924 |
| 2026-05-0616:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-209021 |
| 2026-05-0616:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-208989 |
| 2026-03-2607:18 ET | DEF 14A | Proxy statementPeriod 2026-05-05 | 0001193125-26-125070 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 11, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter
About the filer
- CIK
- 1802255
- Tickers
- GRDN
- Exchange
- NYSE
- SIC code
- 5912 Retail-Drug Stores and Proprietary Stores
- Sector
- Consumer staples
- Fiscal year ends
- Dec 31
- Incorporated in
- GA
- Filer category
- Accelerated filer
- Former names
- Guardian Pharmacy Services, Inc. (to 2026-09-28); Guardian Pharmacy, LLC (to 2021-07-23)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.